Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4857 results found.

Example of search result explained

Lonsurf

Exceptional medication
  • Active ingredient(s):
    trifluridine/tipiracil hydrochloride
  • Manufactured by:
    Taiho Pharma Canada Inc. (Taiho)
  • Strength and dosage form:
    • Tablet 15 mg - 6.14 mg DIN : 2472104
    • Tablet 20 mg - 8.19 mg DIN : 2472112

Dojolvi

Exceptional medication
  • Active ingredient(s):
    triheptanoïne
  • Manufactured by:
    Ultragenyx (Ultragenyx)
  • Strength and dosage form:
    Liquid 100 % DIN : 2512556

JAMP Trospium

Exceptional medication
  • Active ingredient(s):
    trospium chloride
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Tablet 20 mg DIN : 2506661

Mar-Trospium

Exceptional medication
  • Active ingredient(s):
    trospium chloride
  • Manufactured by:
    Marcan Pharmaceuticals Inc. (Marcan)
  • Strength and dosage form:
    Tablet 20 mg DIN : 2488353

Rinvoq

Exceptional medication
  • Active ingredient(s):
    upadacitinib
  • Manufactured by:
    La Corporation AbbVie (AbbVie)
  • Strength and dosage form:
    • Long-Action Tablet 15 mg DIN : 2495155
    • Long-Action Tablet 30 mg DIN : 2520893
    • Long-Action Tablet 45 mg DIN : 2539721

Wezlana

Exceptional medication
  • Active ingredient(s):
    ustekinumab (ulcerative colitis and Crohn's disease)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 99114312
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 99114314
    • Intravenous Perfusion Solution 5 mg/mL (26 mL) DIN : 2544210
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 99114313
    • Subcutaneous Injectable Solution (pen) 45 mg/0.5 mL DIN : 99114443
    • Subcutaneous Injectable Solution (pen) 90 mg/1 mL DIN : 99114444

Wezlana

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2544180
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2544199
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 2544202
    • Subcutaneous Injectable Solution (pen) 90 mg/1 mL DIN : 2553309
    • Subcutaneous Injectable Solution (pen) 45 mg/0.5 mL DIN : 2553317

Jamteki

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2543036
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2543044

Steqeyma

Exceptional medication
  • Active ingredient(s):
    ustekinumab (plaque psoriasis and psoriatic arthritis)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 45 mg/0.5 mL DIN : 2550245
    • Subcutaneous Injectable Solution syringe 90 mg/1 mL DIN : 2550253
    • Subcutaneous Injectable Solution 45 mg/0.5 mL DIN : 2558270

Entyvio

Exceptional medication
  • Active ingredient(s):
    vedolizumab
  • Manufactured by:
    Takeda Canada Inc. (Takeda)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 300 mg DIN : 2436841
Page 129 of 486

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.